glp 1 makers Oral GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important issue is What to Know About New

This study systematically explored the associations between GLP-1RAs and 12 common psychiatric and neurodevelopmental conditions using large-scale GWAS datasets, revealing protective effects against schizophrenia, anxiety disorders, bipolar disorder, bulimia nervosa, PTSD, and autism, with consistent findings across multiple databases for anxiety disorders, autism, and schizophrenia

Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA

GLP-1 Medications Patients choosing between these medications often look at factors such as cost, insurance coverage, dosing preference, and weight loss expectations

Wet the soap with water and lather on your palms